PRIYA SHETTY to Receptor, ErbB-2
This is a "connection" page, showing publications PRIYA SHETTY has written about Receptor, ErbB-2.
Connection Strength
0.039
-
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up. Breast Cancer Res Treat. 2012 Dec; 136(3):795-804.
Score: 0.020
-
Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BMC Cancer. 2012 Jun 13; 12:243.
Score: 0.019